The Leukemia & Lymphoma Society has appointed Bart Kamen, M.D., Ph.D., as chief medical officer (CMO), with the task of co-leading the Society's biomedical research grant programs. His appointment will be effective Sept. 1, 2007....
Read More...
[Source: Society News]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment